Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Status:
Not yet recruiting
Trial end date:
2027-12-15
Target enrollment:
Participant gender:
Summary
This study aims to assess the effect and safety of erenumab compared to placebo for the
treatment of acute posttraumatic headache (PTH) in military service members and civilians
with mild traumatic brain injury (mTBI).
Phase:
Phase 2
Details
Lead Sponsor:
Henry M. Jackson Foundation for the Advancement of Military Medicine